These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19168352)

  • 1. Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors.
    Anandan SK; Do ZN; Webb HK; Patel DV; Gless RD
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1066-70. PubMed ID: 19168352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.
    Anandan SK; Webb HK; Do ZN; Gless RD
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4259-63. PubMed ID: 19520575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method.
    Kowalski JA; Swinamer AD; Muegge I; Eldrup AB; Kukulka A; Cywin CL; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3703-7. PubMed ID: 20472432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
    Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
    J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
    Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW
    Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening.
    Xing L; McDonald JJ; Kolodziej SA; Kurumbail RG; Williams JM; Warren CJ; O'Neal JM; Skepner JE; Roberds SL
    J Med Chem; 2011 Mar; 54(5):1211-22. PubMed ID: 21302953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Chen HS; Tong X; Tong V; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Zhang B; Roy S; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5314-20. PubMed ID: 19682899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibitors: a patent review.
    Shen HC
    Expert Opin Ther Pat; 2010 Jul; 20(7):941-56. PubMed ID: 20429668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
    Imig JD
    Cardiovasc Drug Rev; 2006; 24(2):169-88. PubMed ID: 16961727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
    Kim IH; Morisseau C; Watanabe T; Hammock BD
    J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
    Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
    Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening.
    Moser D; Achenbach J; Klingler FM; Estel la B; Hahn S; Proschak E
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6762-5. PubMed ID: 23017883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adamantyl thioureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Pitushkin D; Karlov D; Fayzullin RR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2302-2313. PubMed ID: 29803731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties.
    Huang SX; Li HY; Liu JY; Morisseau C; Hammock BD; Long YQ
    J Med Chem; 2010 Dec; 53(23):8376-86. PubMed ID: 21070033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.
    Thalji RK; McAtee JJ; Belyanskaya S; Brandt M; Brown GD; Costell MH; Ding Y; Dodson JW; Eisennagel SH; Fries RE; Gross JW; Harpel MR; Holt DA; Israel DI; Jolivette LJ; Krosky D; Li H; Lu Q; Mandichak T; Roethke T; Schnackenberg CG; Schwartz B; Shewchuk LM; Xie W; Behm DJ; Douglas SA; Shaw AL; Marino JP
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3584-8. PubMed ID: 23664879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.